Does renal denervation improve blood pressure and metabolic abnormalities in patients with polycystic ovary syndrome?
Renal denervation may be a potential treatment modality for addressing sympathetic activation, blood pressure, and metabolic abnormalities in polycystic ovary syndrome.
These findings corroborate the relevance of sympathetic activation in PCOS and suggest that renal denervation exerts beneficial effects not only on blood pressure control but also on insulin sensitivity, renal, and endocrine abnormalities characteristic of PCOS.
Schlaich et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: